Mutual Funds Sahi Hai!
To avail the service, you will be redirected to loans.geojitcredits.com
Divis Laboratories Ltd gained for a third straight session today. The stock is quoting at Rs 6247.5, up 1.56% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is up around 0.49% on the day, quoting at 24991.1. The Sensex is at 81715.66, up 0.5%. Divis Laboratories Ltd has slipped around 5.11% in last one month.
Meanwhile, Nifty Pharma index of which Divis Laboratories Ltd is a constituent, has slipped around 1.85% in last one month and is currently quoting at 22265, up 0.34% on the day. The volume in the stock stood at 2.83 lakh shares today, compared to the daily average of 4.49 lakh shares in last one month.
The benchmark August futures contract for the stock is quoting at Rs 6240, up 1.54% on the day. Divis Laboratories Ltd is up 26.82% in last one year as compared to a 0.08% drop in NIFTY and a 0.95% drop in the Nifty Pharma index.
The PE of the stock is 69.89 based on TTM earnings ending June 25.
Over the past month, the stock has fallen 7.08% compared with a 0.84% decline in the Sensex.
Divis Laboratories is engaged in the manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients. The company's consolidated net profit rose 26.74% to Rs 545 crore while net sales rose 13.79% to Rs 2410 crore in Q1 June 2025 over Q1 June 2024.
On a year-on-year (YoY) basis, the company’s net profit rose 26.74%, while revenue increased 13.78%, indicating continued growth over the previous year despite the sequential decline.
Profit before tax for the quarter stood at Rs 733 crore, down 15.16% QoQ but up 21.35% YoY.
The company reported a forex gain of Rs 39 crore during the quarter, compared to a forex loss of Rs 1 crore in the corresponding quarter of the previous financial year.
On a standalone basis, the company’s net profit surged 29.53% to Rs 557 crore on a 14.25% rise in revenue to Rs 2,357 crore in Q1 FY26 over Q1 FY25.
Divis Laboratories is engaged in the manufacture of active pharmaceutical ingredients, intermediates and nutraceutical ingredients.